← Back to Search

Behavioral Intervention

Lifestyle Intervention for Preventing Type 2 Diabetes in Latinos

N/A
Recruiting
Research Sponsored by Arizona State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Children with obesity, defined as BMI ≥ 95th percentile for age and sex
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

Study Summary

This trial will test a lifestyle intervention to see if it can reduce type 2 diabetes risk factors and increase quality of life among high-risk Latino families.

Who is the study for?
This trial is for Latino families with children aged 10-16 who are obese, meaning their BMI is at or above the 95th percentile. Parents and children must not be enrolled in any diabetes prevention or weight loss program recently and should not have type 2 diabetes or conditions affecting metabolism.Check my eligibility
What is being tested?
The study tests a lifestyle intervention aimed at reducing risk factors for type 2 diabetes and improving quality of life among high-risk Latino families. It focuses on diet, exercise, and other daily habits to prevent diabetes.See study design
What are the potential side effects?
Since this is a lifestyle intervention focusing on diet and exercise rather than medication, side effects may include muscle soreness from new physical activities or changes in digestion due to dietary adjustments.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My child is considered obese based on their BMI.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Glucose Tolerance
Secondary outcome measures
Dietary behaviors
Physical Activity
Bone and Bones
+3 more

Side effects data

From 2008 Phase 2 trial • 114 Patients • NCT00151411
35%
Diarrhea
22%
headache/migraine
22%
common cold/respiratory tract infection
16%
nausea and/or vomiting
15%
flu
13%
dysmenorrhea/cramps
11%
stomach/abdominal pain or discomfort
9%
musculoskeletal
5%
vaginal infection
5%
dizziness
5%
hair loss
5%
dental issues
4%
fatigue
4%
flatulence
2%
bladder infection
100%
80%
60%
40%
20%
0%
Study treatment Arm
Placebo
Metformin

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Lifestyle InterventionExperimental Treatment1 Intervention
16-week family-focused intervention that includes nutrition education, behavioral change skills training, and physical activity.
Group II: Comparison controlActive Control1 Intervention
Comparison control families meet with the Study Physician and a Registered Dietitian as a family to review laboratory results and receive lifestyle counseling. Control families will be contacted on a monthly basis for a total of 12 months.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Lifestyle Intervention
2001
Completed Phase 2
~8880

Find a Location

Who is running the clinical trial?

Phoenix Children's HospitalOTHER
74 Previous Clinical Trials
5,013,883 Total Patients Enrolled
St. Vincent de Paul Medical and Dental ClinicOTHER
2 Previous Clinical Trials
152 Total Patients Enrolled
University of WashingtonOTHER
1,743 Previous Clinical Trials
1,847,738 Total Patients Enrolled

Media Library

Lifestyle Intervention (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05228522 — N/A
Type 2 Diabetes Research Study Groups: Comparison control, Lifestyle Intervention
Type 2 Diabetes Clinical Trial 2023: Lifestyle Intervention Highlights & Side Effects. Trial Name: NCT05228522 — N/A
Lifestyle Intervention (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05228522 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals have enrolled in this clinical experiment?

"Absolutely. Clinicaltrials.gov confirms that this clinical experiment, which was originally written on December 12th 2021, is actively searching for participants. 132 individuals are being accepted at a single site."

Answered by AI

Do I fit the requirements to enter this scientific evaluation?

"The criteria for admittance into this clinical trial is pediatric obesity, and an age range of 10-99 years old. An approximate 132 individuals are being accepted as participants in the study."

Answered by AI

Is this research available to the public at present?

"Affirmative. The information available on clinicaltrials.gov verifies that this scientific trial, established December 12th 2021, is actively engaging participants in recruitment efforts. A total of 132 volunteers are necessary from just one medical facility."

Answered by AI

Is the study open to geriatric patients?

"This clinical trial allows for participation between the ages of 10 and 99, as per its inclusion criteria."

Answered by AI

Who else is applying?

What site did they apply to?
Arizona State University
What portion of applicants met pre-screening criteria?
Did not meet criteria
~40 spots leftby May 2025